Madam Kumari, as she is known, has osteoporosis or brittle bones. The condition typically presents without any warning ...

University of Alberta-led researchers, including the developers and promoters of the Fracture Risk Assessment Tool (FRAX), ...

As the world celebrated the highest level of athletic excellence in Paris during the Summer Olympics this year, champions of ...

"Angitia doses first subject in Phase II trial of AGA2118 for treating osteoporosis" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Although fracture risk in the premenopausal population is low, women with secondary osteoporosis may benefit from treatment with various agents, depending upon the condition. Premenopausal women ...

FRAX has been validated for fracture risk assessment for patients with cancer, with HRs indicating an association between ...

Phase 2 study to be conducted in the US and EUWOODLAND HILLS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

The AIIMS Trauma Centre unveils a weekly clinic dedicated to helping elderly patients manage osteoporosis and prevent fragility fractures. The program aims to enhance bone health and improve quality ...

shared that risk factors for secondary osteoporosis can be classified into non-modifiable and modifiable risk factors - Non-modifiable risk factors include female gender, increasing age ...